Hatchtech Pty Ltd to explore strategic alternatives for commercialization of Xeglyze™ lotion in the U.S.

26 March 2015

Learn More

Abbie Lewis

Author

Abbie Lewis

Abbie plays a key role in delivering OneVentures’ marketing, PR, community and branding initiatives, strengthening the firm’s identity and amplifying the visibility of our portfolio companies. Before joining OneVentures, Abbie worked at 89up in London, Europe’s first impact PR agency, where she contributed to global campaigns for NGOs.

You may also like

02 August 2020

Healthcare

FDA Approves Xeglyze™ for the topical treatment of head lice infestation


02 August 2020

Healthcare

Hatchtech gets lice treatment nod from FDA


01 February 2018

OneVentures

No nit picking: Head lice group Hatchtech gets green light to trials


14 September 2015

OneVentures

Hatchtech inks $279m head lice deal as VC market comes to life


View All